Ahead of the Curve: AOTC CFTR at 25 -Clinician & Patient Perspectives
Ahead of the Curve: The Diagnostic & Therapeutic Challenge consists of one activity certified for a maximum of AMA PRA Category 1 Credit(s)™ and delivered as a webcast or podcast. Upon release of this activity, participants will have up to 2 years to complete the webcast or podcast in order to earn CME credit.
Target Audience
Pulmonologists, pediatric pulmonologists, gastroenterologists, infectious disease physicians, endocrinologists, respiratory therapists, pediatricians, nurse practitioners, nurses, and other members of the cystic fibrosis team.
Learning Objectives
After participating in this activity, the participant will demonstrate the ability to:
- Explain how new CFTR modification advances point to changes that have to be made in clinical practice.
- Describe the utility of genotype/phenotype correlations beyond diagnosis in achieving more effective patient treatment.
- Integrate the patient into an individualized therapy regimen to improve outcomes.
Patrick Sosnay, MD
Assistant Professor of Medicine
Division of Pulmonary & Critical Care Medicine,
McKusick-Nathans Institute for Genetic Medicine
Johns Hopkins Cystic Fibrosis Center
The Johns Hopkins University
Baltimore, Maryland
Stuart Elborn, MD
Professor, School of Medicine, Dentistry and Biomedical Sciences
Dean, School of Medicine, Dentistry and Biomedical Sciences
Centre for Infection and Immunity
Queen’s University
Belfast, Ireland
Joseph Pilewski, MD
Associate Professor of Medicine, Cell Biology, Physiology & Pediatrics
University of Pittsburgh
Pittsburgh, PA
Meghan Ramsay, MS, CRNP
Adult Clinical Coordinator, Cystic Fibrosis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland
Available Credit
- 1.50 ANCC